December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Applied Therapeutics, Inc. - Common Stock (NQ:APLT)

0.1154 -0.0003 (-0.26%)
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Applied Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Halper Sadeh LLC Encourages ALEX, DXLG, APLT Shareholders to Contact the Firm to Discuss Their Rights
Shareholders should contact the firm immediately as there may be limited time to enforce your rights 
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
APLT Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Applied Therapeutics, Inc. is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Cycle Pharmaceuticals to Acquire Applied Therapeutics
Applied Therapeutic’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor for the treatment of CNS rare metabolic diseases 
From Applied Therapeutics
Via GlobeNewswire
News headline image
Applied Therapeutics Announces Corporate Updates
From Applied Therapeutics
Via GlobeNewswire
News headline image
Applied Therapeutics Reports Third Quarter 2025 Financial Results
From Applied Therapeutics
Via GlobeNewswire
News headline image
Halper Sadeh LLC Encourages Applied Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
Applied Therapeutics Provides Update Following Meeting with FDA
From Applied Therapeutics
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); Elevance Health Inc. (NYSE: ELV); and V.F. Corp. (NYSE: VFC): Grabar Law Office is Investigating Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); Ibotta Inc. (NYSE: IBTA); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your
From Grabar Law Office
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); LuxUrban Hotels Inc. (OTC: LUXH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims
From Grabar Law Office
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Lantheus Holdings, Inc. (NASDAQ: LNTH); Savara Inc. (NASDAQ: SVRA); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your
From Grabar Law Office
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Applied Therapeutics Reports Second Quarter 2025 Financial Results
From Applied Therapeutics
Via GlobeNewswire
News headline image
Applied Therapeutics Announces Key Leadership Appointments
From Applied Therapeutics
Via GlobeNewswire
News headline image
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
From Applied Therapeutics
Via GlobeNewswire
News headline image
Applied Therapeutics Reports First Quarter 2025 Financial Results
From Applied Therapeutics
Via GlobeNewswire
News headline image
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
Late-breaking oral presentation to include full 12-month clinical data from INSPIRE registrational Phase 3 trial in addition to topline 18-month and 24-month data from patients prior to open-label... 
From Applied Therapeutics
Via GlobeNewswire
News headline image
Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
From Applied Therapeutics
Via GlobeNewswire
News headline image
Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission
From Applied Therapeutics
Via GlobeNewswire
News headline image
Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer
Dr. Baumgartner will advance Applied’s preparation for upcoming regulatory interactions 
From Applied Therapeutics
Via GlobeNewswire
News headline image
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
Final APLT Deadline Reminder: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Final APLT Deadline Reminder: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer &amp; Check, LLP
RADNOR, PA - February 18, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Applied... 
Via TheNewswire.com
Topics Lawsuit
News headline image
APLT Deadline in 1 Day: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
APLT Deadline in 1 Day: Kessler Topaz Meltzer &amp; Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
RADNOR, PA - February 17, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Applied... 
Via TheNewswire.com
Topics Lawsuit
News headline image
APLT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
DEADLINE TOMORROW: Kaplan Fox Reminds Investors of a Deadline for a Securities Class Action Lawsuit Against Applied Therapeutics (APLT)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
DEADLINE TOMORROW: Kaplan Fox Reminds Investors of a Deadline for a Securities Class Action Lawsuit Against Applied Therapeutics (APLT)
NEW YORK - February 17, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or the... 
Via TheNewswire.com
Topics Lawsuit
News headline image
APLT Deadline: Rosen Law Firm Urges Applied Therapeutics, Inc. (NASDAQ: APLT) Investors to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
APLT Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.